S. Lindemalm et al., STABILITY AND ANALYSIS OF 2-CHLORO-2'-DEOXYADENOSINE, 2-CHLORO-2'-ARABINO-FLUORO-2'-DEOXYADENOSINE AND 2-CHLOROADENINE IN HUMAN BLOOD-PLASMA, Anti-cancer drugs, 8(5), 1997, pp. 445-453
Cladribine (2-chloro-2'-deoxyadenosine, CdA) is a purine nucleoside an
alog with activity against lymphoproliferative and autoimmune disorder
s. 2-Chloro-2'-arabino-fluoro-2'-deoxyadenosine (CAFdA), a derivative
of CdA with better acid stability, shows a similar in vitro spectrum o
f activity as CdA. 5-Chloroadenine (CAde) is the major catabolite of b
oth CdA and CAFdA. We have developed a high performance liquid chromat
ography method to measure CdA, CAFdA and their metabolite CAde in plas
ma. This method employees an internal standard, chloroadenosine (CAdo)
, and a C-8 solid-phase extraction to isolate and concentrate the subs
tances. Chromatographic separation was achieved using a C-8 reverse-ph
ase column, with UV detection at 265 nm, which gives a limit of detect
ion of 1 nmol/l for all substances. The method was reproducible with i
ntra- and inter-assay coefficients of variations below 6% at 50 nmol/l
and at 5 nmol/l below 23%. The average recoveries of CdA, CAde, CAFdA
and the internal standard were higher than 70%. Stability studies of
authentic patient samples show that samples containing CdA should be k
ept in a refrigerator or on ice to prevent degradation. plasma contain
ing CAde should not be kept at -20 degrees C for longer than 10 weeks
before analysis. CdA and CAFdA remain almost stable during storage at
-20 degrees C for 12 weeks.